Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
The Alopecia Areata Severity and Morbidity Index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity 10.1001/jamadermatol.2023.5869
Artificial intelligence in skin cancer diagnosis: a reality check 10.1016/j.jid.2023.10.004
Causes and clinical presentation of drug-induced dermatomyositis 10.1001/jamadermatol.2023.5418
Clinical features and outcomes of black patients with melanoma 10.1001/jamadermatol.2023.5789
Compression for preventing recurrence of venous ulcers (updated Cochrane intervention review) 10.1002/14651858.CD002303.pub4
Efficacy and safety of PF-07038124 in patients with atopic dermatitis and plaque psoriasis 10.1001/jamadermatol.2023.4990
Erythromelalgia: pathogenesis, clinical features, evaluation, and complications 10.1016/j.jaad.2023.02.071; differential diagnoses and management 10.1016/j.jaad.2023.02.070
Federated learning for decentralized artificial intelligence in melanoma diagnostics 10.1001/jamadermatol.2023.5550
Genetic risk factors for early-onset Merkel cell carcinoma 10.1001/jamadermatol.2023.5362
Human hair graying revisited: principles, misconceptions, and key research frontiers 10.1016/j.jid.2023.09.276
Lived experience of acne and acne treatment in transgender patients 10.1001/jamadermatol.2023.5355
Nail psoriasis and nail lichen planus: updates on diagnosis and management 10.1016/j.jaad.2023.11.024
Pachyonychia congenita: a research agenda leading to new therapeutic approaches s10.1016/j.jid.2023.10.030
Petroleum jelly: a comprehensive review of its history, uses, and safety 10.1016/j.jaad.2023.06.010
Prevalence of pretreatment testing recommended for patients with chronic inflammatory skin diseases 10.1001/jamadermatol.2023.5895
Proteolytic and antiproteolytic activity in the skin: gluing the pieces together 10.1016/j.jid.2023.08.010
Role of antigenic stimulation in cutaneous T-cell lymphomas 10.1016/j.jid.2023.10.023
Short-term cardiovascular complications in dermatology patients receiving JAK-STAT inhibitors 10.1001/jamadermatol.2023.5509
The skin molecular ecosystem holds the key to nevogenesis and melanomagenesis 10.1016/j.jid.2023.09.271
Unmet needs for patients with seborrheic dermatitis 10.1016/j.jaad.2022.12.017
Cochrane Library (Mar); JAMA Dermatology (Feb-Mar); Journal of Investigative Dermatology (Mar-Apr); Journal of the American Academy of Dermatology (Mar-Apr)
Cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: a systematic review and meta-analysis DOI: 10.1001/jamadermatol.2023.4090
A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies DOI: 10.1016/j.jaad.2023.10.021
Cutaneous granulomas associated with rubella virus DOI: 10.1016/j.jaad.2023.05.058
Cutaneous melioidosis: an updated review and primer for the dermatologist DOI: 10.1016/j.jaad.2023.07.1032
Emerging role of the IL-36/IL-36R axis in multiple inflammatory skin diseases DOI: 10.1016/j.jid.2023.11.004
Epidemiology, clinical characteristics, treatment, and outcomes of proliferating pilar tumors: A systematic review DOI: 10.1016/j.jaad.2023.05.097
Extracellular vesicles in the skin microenvironment: emerging roles as biomarkers and therapeutic tools in dermatologic health and disease DOI: 10.1016/j.jid.2023.08.024
Genomic profiling of the overlap phenotype between psoriasis and atopic dermatitis DOI: 10.1016/j.jid.2023.06.194
Inborn errors of immunity contribute to the burden of skin disease and create opportunities for improving the practice of dermatology DOI: 10.1016/j.jid.2023.08.018
Janus kinase inhibitors and adverse events of acne DOI: 10.1001/jamadermatol.2023.3830
Outcome measures for the evaluation of treatment response in hidradenitis suppurativa for clinical practice: a HiSTORIC consensus statement DOI: 10.1001/jamadermatol.2023.3282
Patient perspectives on social risk screening and documentation in a dermatology clinic DOI: 10.1001/jamadermatol.2023.3887
Pressure alopecias: A review DOI: 10.1016/j.jaad.2023.07.009
The risk of keratinocyte cancer in vitiligo and the potential mechanisms involved DOI: 10.1016/j.jid.2023.08.012
Risk of paradoxical eczema in patients receiving biologics for psoriasis DOI: 10.1001/jamadermatol.2023.4846
Risk of suicide and psychiatric disorders among isotretinoin users: a meta-analysis DOI: 10.1001/jamadermatol.2023.4579
Safety and effectiveness of oral nutraceuticals for treating acne: a systematic review DOI: 10.1001/jamadermatol.2023.3949
SARS-CoV-2–induced vasculitic skin lesions are associated with massive spike protein depositions in autophagosomes DOI: 10.1016/j.jid.2023.07.018
Sources used: JAMA Dermatology (Nov, Dec, Jan); Journal of Investigative Dermatology (Dec, Jan, Feb); Journal of the American Academy of Dermatology (Dec, Jan, Feb)
Alpha-gal syndrome: A review for the dermatologist DOI: 10.1016/j.jaad.2023.04.054
Androgenetic alopecia in transgender and gender diverse populations DOI: 10.1016/j.jaad.2021.08.067
Applications of human pluripotent stem cell–derived skin organoids in dermatology DOI: 10.1016/j.jid.2023.07.017
Baricitinib for treating severe alopecia areata (new NICE guideline TA926)
Bimekizumab for treating active psoriatic arthritis (new NICE guideline TA916)
Clinical outcomes for uptitration of baricitinib therapy in patients with severe alopecia areata DOI: 10.1001/jamadermatol.2023.2581
Cutaneous adverse events and cancer survival prognosis with immune checkpoint inhibitor treatment DOI: 10.1001/jamadermatol.2023.3003
Diagnosis, assessment and management of atopic dermatitis in children with skin of colour DOI: 10.31128/AJGP-01-23-6684
Excessive production of hydrogen peroxide in mitochondria contributes to atopic dermatitis DOI: 10.1016/j.jid.2023.03.1680
Extracellular matrix–derived damage-associated molecular patterns (DAMP) DOI: 10.1016/j.jid.2023.04.030
Feasibility of adipose-derived therapies for hair regeneration DOI: 10.1016/j.jaad.2021.11.058
Gaps in medical education curricula on skin of color in medical school, residency, and beyond DOI 10.1016/j.jaad.2022.03.053
Hidradenitis suppurativa in sexual and gender minorities DOI: 10.1016/j.jaad.2022.03.008
Implementing patient safety and quality improvement in dermatology Patient safety science DOI 10.1016/j.jaad.2022.01.049; Quality improvement science DOI: 10.1016/j.jaad.2022.01.050
Phacomatosis spilosebacea (review) DOI: 10.1016/j.jaad.2020.12.082
Racial and ethnic disparities in clinical research and the dermatology workforce DOI: 10.1016/j.jaad.2022.03.052
Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children DOI: 10.1016/j.jid.2023.03.1682
Relatlimab–nivolumab: A practical overview for dermatologists DOI: 10.1016/j.jaad.2023.06.024
Risk of melanoma and nonmelanoma skin cancer in people with vitiligo DOI: 10.1016/j.jid.2023.04.013
Topical and oral steroids for otitis media with effusion in children (new Cochrane review) DOI: 10.1002/14651858.CD015255.pub2/full
Treatments for alopecia areata (new Cochrane review) DOI: 10.1002/14651858.CD013719.pub2
White hair in alopecia areata DOI: 10.1016/j.jaad.2018.12.047
Sources used: Australian Journal of General Practice (Oct); Cochrane Library (Oct); JAMA Dermatology (Sep, Oct); Journal of Investigative Dermatology (Oct, Nov); Journal of the American Academy of Dermatology (Oct, Nov); NICE (Oct)